Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
Daniel Pereira Monteiro, Founder and Education Lead of Haemopaedia, Screening Professional Scientific Advisor at NHS England, shared a post on LinkedIn:
“We know that beta thalassaemia major is a severe condition… but do you know why?
Let’s test your haemoglobinopathy interpretation skills
Would you like to know:
- What is beta thalassaemia major?
- What causes it?
- What happens physiologically to try to compensate?
- How would you spot it in the laboratory?
Welcome to Haemopaedia Case of the Week
This case counts towards your monthly CPD Certificate!
You are free to participate, here is how:
- Submit your answer via the Haemopaedia form available in the comment section
- Drop your interpretation also in the comments below
Both steps are required for CPD recognition
Want to know about upcoming training sessions, webinars and case-based learning every week, straight to your email?
Signing up to Haemopaedia’s LabLines Newsletter.
But you are free to unsubscribe at any time.
Have a case you’d like featured?
DM me to share an anonymised example for future posts.
I’m Daniel Monteiro.
I help students and healthcare professionals, including biomedical scientists, nurses, and doctors, to master the complexities of hemoglobinopathy screening and diagnosis through evidence-based guidance and real-world case studies.
I founded Haemopaedia to provide scientifically rigorous training material for everyone, from laboratory scientists to clinicians looking to deepen their understanding of hemoglobinopathies or who simply like to have a diagnostic challenge
Disclaimer:
All cases shared in these series are for educational purposes only and do not constitute clinical or diagnostic advice.
Contributors are reminded to make sure all examples are fully anonymised and shared in accordance with their local governance and confidentiality policies.”
Other posts featuring Daniel Pereira Monteiro on Hemostasis Today.
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy
-
Jun 26, 2026, 15:51Heghine Khachatryan: Willebrand Disease – Similar Bleeding Phenotype, Distinct Pathophysiology